Influence of debrisoquin phenotype on the inducibility of propranolol metabolism.

Détails

ID Serval
serval:BIB_61B7032FD7EA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Influence of debrisoquin phenotype on the inducibility of propranolol metabolism.
Périodique
Clinical Pharmacology and Therapeutics
Auteur⸱e⸱s
Shaheen O., Biollaz J., Koshakji R.P., Wilkinson G.R., Wood A.J.
ISSN
0009-9236 (Print)
ISSN-L
0009-9236
Statut éditorial
Publié
Date de publication
1989
Volume
45
Numéro
4
Pages
439-443
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, U.S. Gov't, P.H.S.
Publication Status: ppublish
Résumé
The effects of rifampin (600 mg) once daily for 22 days on the total and fractional metabolic clearances of propranolol were determined in a group of six genetically extensive (EM) and six poor metabolizers (PM) of debrisoquin. The impaired ability of PMs to metabolize propranolol to the ring-oxidized metabolite 4-hydroxypropranolol was confirmed. The total oral clearance of propranolol increased about fourfold in both phenotypes from 219.2 +/- 52.8 to 976.7 L/hr in the EMs and from 75.0 +/- 12.6 to 289.8 +/- 78.2 L/hr in the PMs. The extent of induction of glucuronidation was similar in the two groups. 4-Hydroxylation was induced in both phenotypes but the increase was fifteenfold greater in EMs than in PMs. This would imply that the cytochrome P-450 determined by the debrisoquin allele or some coinherited 4-hydroxylase(s) was induced to a greater extent in EMs than PMs.
Mots-clé
Adult, Debrisoquin/pharmacology, Enzyme Induction/drug effects, Glucuronates/urine, Humans, Isoquinolines/pharmacology, Male, Metabolic Clearance Rate/drug effects, Mixed Function Oxygenases/metabolism, Phenotype, Propranolol/analogs & derivatives, Propranolol/metabolism
Pubmed
Web of science
Création de la notice
25/01/2008 11:41
Dernière modification de la notice
20/08/2019 15:18
Données d'usage